Zhao Hailin, Alam Azeem, San Chun-Yin, Eguchi Shiori, Chen Qian, Lian Qingquan, Ma Daqing
Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK.
Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK; Department of Anaesthesiology, Southwest Hospital, Third Military Medical University, Chongqing, China.
Brain Res. 2017 Jun 15;1665:1-21. doi: 10.1016/j.brainres.2017.03.029. Epub 2017 Apr 7.
Neuronal cell injury, as a consequence of acute or chronic neurological trauma, is a significant cause of mortality around the world. On a molecular level, the condition is characterized by widespread cell death and poor regeneration, which can result in severe morbidity in survivors. Potential therapeutics are of major interest, with a promising candidate being brain-derived neurotrophic factor (BDNF), a ubiquitous agent in the brain which has been associated with neural development and may facilitate protective and regenerative effects following injury. This review summarizes the available information on the potential benefits of BDNF and the molecular mechanisms involved in several pathological conditions, including hypoxic brain injury, stroke, Alzheimer's disease and Parkinson's disease. It further explores the methods in which BDNF can be applied in clinical and therapeutic settings, and the potential challenges to overcome.
作为急性或慢性神经创伤的结果,神经元细胞损伤是全球范围内一个重要的死亡原因。在分子水平上,这种情况的特征是广泛的细胞死亡和再生能力差,这可能导致幸存者出现严重的发病情况。潜在的治疗方法备受关注,一种有前景的候选药物是脑源性神经营养因子(BDNF),它是大脑中一种普遍存在的因子,与神经发育有关,并且可能在损伤后促进保护和再生作用。这篇综述总结了关于BDNF潜在益处以及在几种病理状况(包括缺氧性脑损伤、中风、阿尔茨海默病和帕金森病)中所涉及分子机制的现有信息。它进一步探讨了BDNF可应用于临床和治疗环境的方法以及需要克服的潜在挑战。